Semaglutide for type 2 diabetes.
Författaruppgift saknas
Aust Prescr · review-article; review; journal article · DOI 10.18773/austprescr.2020.046 PUBLICATION REGISTRY
Go to research.
Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.
Publikationer som ChEBI hänvisar till för semaglutide. Visa hela publikationsregistret
A publication hit is not a conclusion. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.
Publications in the selection
43 hitsSemaglutide injection for the treatment of adults with type 2 diabetes.
Chudleigh RA, Bain SC.
Expert Rev Clin Pharmacol · comparative study; review; journal article · DOI 10.1080/17512433.2020.1776108Semaglutide in Cystic Fibrosis-Related Diabetes.
Gnanapragasam H, Mustafa N, Bierbrauer M, Andrea Providence T, Dandona P.
J Clin Endocrinol Metab · journal article; case reports · DOI 10.1210/clinem/dgaa167ACTUALITIES IN ENDOCRINE PHARMACOLOGY: ADVANCES IN THE DEVELOPMENT OF ORAL FORMULATIONS FOR CALCITONIN AND SEMAGLUTIDE.
Hamza A, Șaramet G.
Acta Endocrinol (Buchar) · research-article; journal article · DOI 10.4183/aeb.2020.383Oral semaglutide in type 2 diabetes.
Anderson SL, Beutel TR, Trujillo JM.
J Diabetes Complications · review; journal article · DOI 10.1016/j.jdiacomp.2019.107520Oral Semaglutide.
Hughes S, Neumiller JJ.
Clin Diabetes · research-article; journal article · DOI 10.2337/cd19-0079An overview of GLP-1 agonists and recent cardiovascular outcomes trials.
Sheahan KH, Wahlberg EA, Gilbert MP.
Postgrad Med J · review-article; review; journal article · DOI 10.1136/postgradmedj-2019-137186Oral semaglutide (Rybelsus) for type 2 diabetes.
Författaruppgift saknas
Med Lett Drugs Ther · review; journal article[Semaglutide, once weekly GLP-1 receptor agonist (Ozempic®)].
Scheen AJ.
Rev Med Liege · journal articleSemaglutide (Ozempic) for Type 2 Diabetes Mellitus.
Chamberlin S, Dabbs W.
Am Fam Physician · journal articleSemaglutide is Neuroprotective and Reduces α-Synuclein Levels in the Chronic MPTP Mouse Model of Parkinson's Disease.
Zhang L, Zhang L, Li L, Hölscher C.
J Parkinsons Dis · comparative study; research support, non-u.s. gov't; journal article · DOI 10.3233/jpd-181503Subcutaneous semaglutide (NN9535) for the treatment of type 2 diabetes.
Hedrington MS, Tsiskarishvili A, Davis SN.
Expert Opin Biol Ther · review; journal article · DOI 10.1080/14712598.2018.1439014The human GLP-1 analogs liraglutide and semaglutide: absence of histopathological effects on the pancreas in nonhuman primates.
Gotfredsen CF, Mølck AM, Thorup I, Nyborg NC, Salanti Z, Knudsen LB, Larsen MO.
Diabetes · comparative study; journal article · DOI 10.2337/db13-1087